{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:40:24Z","timestamp":1791895224552,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Faculty of Medical Sciences, Tarbiat Modares University"},{"DOI":"10.13039\/501100003968","name":"Iran National Sciences Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.peptides.2012.02.023","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T11:19:29Z","timestamp":1331032769000},"page":"56-59","source":"Crossref","is-referenced-by-count":24,"title":["Orexin receptor type-1 antagonist SB-334867 inhibits the development of morphine analgesic tolerance in rats"],"prefix":"10.1016","volume":"35","author":[{"given":"Yadollah","family":"Ranjbar-Slamloo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaghoub","family":"Fathollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Semnanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2012.02.023_bib0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjp.0707277","article-title":"Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of l- and d-opioid receptor antagonists","volume":"151","author":"Abul-Husn","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2012.02.023_bib0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0163-1047(80)90354-4","article-title":"Evidence for conditioned tolerance of the tail flick reflex","volume":"29","author":"Advokat","year":"1980","journal-title":"Behav Neural Biol"},{"key":"10.1016\/j.peptides.2012.02.023_bib0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2009.09.106","article-title":"Lateral hypothalamic orexin\/hypocretin neurons: a role in reward-seeking and addiction","volume":"1314","author":"Aston-Jones","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2012.02.023_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neulet.2010.07.050","article-title":"Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats","volume":"482","author":"Azizi","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2012.02.023_bib0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.22002","article-title":"How to design an opioid drug that causes reduced tolerance and dependence","volume":"67","author":"Berger","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.peptides.2012.02.023_bib0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00109-002-0322-x","article-title":"Orexins: from neuropeptides to energy homeostasis and sleep\/wake regulation","volume":"80","author":"Beuckmann","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/j.peptides.2012.02.023_bib0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/1874473710801020222","article-title":"Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery","volume":"1","author":"Garz\u00f3n","year":"2008","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.peptides.2012.02.023_bib0040","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","article-title":"Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal","volume":"23","author":"Georgescu","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2012.02.023_bib0045","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/00000542-200305000-00037","article-title":"Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests","volume":"98","author":"Gilron","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.peptides.2012.02.023_bib0050","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1007\/s00018-008-8206-z","article-title":"Multiple phospholipase activation by OX1 orexin\/hypocretin receptors","volume":"65","author":"Johansson","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.peptides.2012.02.023_bib0055","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0022-3565(24)37114-9","article-title":"The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids","volume":"283","author":"Kest","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2012.02.023_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.1189","article-title":"Mapping of the mRNAs for the hypocretin\/orexin and melanin-concentrating hormone receptors: networks of overlapping peptide systems","volume":"435","author":"Kilduff","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.peptides.2012.02.023_bib0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neulet.2006.08.091","article-title":"Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia","volume":"410","author":"Liu","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2012.02.023_bib0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-3959(96)81972-5","article-title":"Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance","volume":"67","author":"Manning","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.peptides.2012.02.023_bib0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.12.013","article-title":"Inhibition of tolerance to spinal morphine antinociception by low doses of opioid receptor antagonists","volume":"560","author":"McNaull","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.peptides.2012.02.023_bib0080","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00213-007-0984-8","article-title":"NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats","volume":"196","author":"Mendez","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.peptides.2012.02.023_bib0085","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/bjp.2008.353","article-title":"Low doses of a2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance","volume":"155","author":"Milne","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2012.02.023_bib0090","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1460-9568.2004.03255.x","article-title":"Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus","volume":"19","author":"Muroya","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.peptides.2012.02.023_bib0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/smns.1997.0109","article-title":"Molecular mechanisms underlying opiate addiction: implications for medications development","volume":"9","author":"Nestler","year":"1997","journal-title":"Semin Neurosci"},{"key":"10.1016\/j.peptides.2012.02.023_bib0100","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.peptides.2012.02.023_bib0105","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1152\/jn.00968.2002","article-title":"Excitatory effects of hypocretin 1 (orexin A) in the trigeminal motor nucleus are reversed by NMDA antagonism","volume":"89","author":"Peever","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.peptides.2012.02.023_bib0110","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2012.02.023_bib0115","first-page":"1472","article-title":"Deletion of the inducible nitric oxide synthase gene reduces peripheral morphine tolerance in a mouse model of chronic inflammation","volume":"10","author":"Romero","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.peptides.2012.02.023_bib0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2008.03.006","article-title":"Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell","volume":"64","author":"Sharf","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.peptides.2012.02.023_bib0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrn808","article-title":"The hypocretins: setting the arousal threshold","volume":"3","author":"Sutcliffe","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.peptides.2012.02.023_bib0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pain.2006.01.019","article-title":"Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains","volume":"122","author":"Terner","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.peptides.2012.02.023_bib0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol Rev"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112001143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112001143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T14:34:54Z","timestamp":1742654094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978112001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0196978112001143"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2012.02.023","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}